September 20, 2007 - Medicure Inc. today announced the completion of enrollment of 3,000 patients in its MEND-CABG II trial, as the company plans to develop the first cardioprotective therapy approved to reduce mortality and morbidity in the CABG patient population.

September 20, 2007 - Cook Medical and Cardica Inc. announced that they have expanded their original agreement regarding the development of vascular closure devices, in which Cook Medical will pay Cardica up to $750,000 for the development of an additional product for the closure device product line.

September 19, 2007 - Biotronik announced that it has been awarded a full-service cardiac rhythm management (CRM) contract with Premier Purchasing Partners L.P., a healthcare purchasing alliance, which will allow Premier members to purchase Biotronik pacemakers, implantable defibrillators and cardiac resynchronization devices at exceptional savings.

The new agreement marks the first time that Biotronik has offered its full product portfolio to the Premier alliance on contract.

September 19, 2007 - MedicalCV Inc. announced that the first closed-chest, beating heart cardiac ablation using the SOLAR Surgical Ablation System was performed, marking a growing trend in minimally invasive surgical ablation.

September 19, 2007 - Polymer Technology Systems Inc. (PTS) announced the availability of a new PTS Panels Test Strip to test important risk factors for cardiovascular disease and diabetes.

September 19, 2007 - For patients with equivocal or discordant findings on myocardial perfusion imaging, CT angiography (CTA) can unmask false-negative and false-positive results, according to Regina S. Druz, M.D., North Shore University Hospital in Manhasset, N.Y., told attendees at the American Society of Nuclear Cardiology meeting.

September 19, 2007 - With better quality sound, reproducibility potential for computer analysis, file-sharing and verification, the MP3 player could be used in place of a traditional stethoscope, reported Neil Skjodt, the Department of Medicine at the University of Alberta, Canada, at the annual Congress of the European Respiratory Society (ERS) in Stockholm, Sweden.

September 19, 2007 - Risk stratification using single-photon emission computed tomography (SPECT) led to shorter stays and fewer readmissions for hospitalized heart attack patients, according to a preliminary study presented by James Spalding, PharmD, at the American Society of Nuclear Cardiology meeting, held in San Diego, CA, from September 6 – 9.

The researchers found that stress SPECT was associated with significant reductions in:

September 18, 2007- With PET-guided lead placement, cardiac resynchronization therapy (CRT) can achieve significant clinical improvement in patients with severe ischemic heart failure, even in the presence of extensive scarring, reported investigators at the American Society of Nuclear Cardiology meeting, held in San Diego, CA, from September 6 – 9.

September 18, 2007 - Angiotech Pharmaceuticals Inc. announced that it reached a favorable agreement with Johnson & Johnson’s subsidiary, Conor Medsystems ("Conor") to settle all outstanding patent litigation with respect to Conor's CoStar paclitaxel stent.

"With this agreement now in place, Angiotech expects that the resources required to defend and enforce our intellectual property should decrease," said Dr. William Hunter, president and CEO of Angiotech.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now